Optimal control of vertically transmitted disease: An integrated approach

Computational and Mathematical Methods in Medicine

Volumn 11, Issue 4, 2010, Pages 369-387

  Bhattacharyya, Samit ^a   Ghosh, Suma ^b  

^a UNIVERSITY OF GUELPH   (Canada)

^b YORK UNIVERSITY   (Canada)

Author keywords

Basic reproduction ratio; Optimal control; Pontryagin maximum principle; Stability analysis; Vertically transmitted disease

Indexed keywords

CONTROLLED DRUG DELIVERY; COST EFFECTIVENESS; DISEASE CONTROL; DISEASES; TARGETED DRUG DELIVERY; VACCINES;

ANTI-VIRAL DRUGS; BASIC REPRODUCTION RATIOS; HORIZONTAL TRANSMISSIONS; INTEGRATED APPROACH; INTERVENTION STRATEGY; OPTIMAL CONTROLS; PONTRYAGIN'S MAXIMUM PRINCIPLE; STABILITY ANALYZE; VERTICAL TRANSMISSION; VERTICALLY TRANSMITTED DISEASE;

MAXIMUM PRINCIPLE;

ANTIVIRUS AGENT; HEPATITIS B VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNITY; INFECTION CONTROL; MEDICAL PARAMETERS; PROBABILITY; PROGENY; REINFECTION; VACCINATION; VERTICAL TRANSMISSION;

EID: 78149432958     PISSN: 1748670X     EISSN: 17486718     Source Type: Journal    
DOI: 10.1155/2010/520830     Document Type: Article

References (34)

1. N. Bailey, The Mathematical Theory of Infectious Diseases, 2nd ed., Hafner, New York, 1975.
2. F. Baryarama, J.Y.T. Mugisha, and L.S. Lubooobi, Mathematical model for HIV/AIDS with complacency in a population with declining prevalence, Comput. Math. Methods Med. 7 (2006), pp. 27-35.
3. P.E. Beitune, G. Duarte, S.M. Quintana, E.A. Figueiró-Filho, A.C. Marcolin and R. Abduch, Antiretroviral therapy during pregnancy and early neonatal life: Consequences for HIV-exposed, uninfected children, Braz. J. Infect. Dis. 8 (2004), pp. 140-150.
4. S. Bhattacharyya and D.K. Bhattacharya, A more realistic approach to pest management, Bull. Math. Biol. 69 (2007a), pp. 1277-1310.
5. S. Bhattacharyya and D.K. Bhattacharya, An improved integrated pest management model under 2-control parameters (sterile male and pesticide), Math. Biosci. 209 (2007b), pp. 256-281.
6. B.S. Bloom, A.L. Hillman, A.M. Fendrick, and J.S. Schwartz, A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis, Ann. Intern. Med. 118 (1993), pp. 298-306.
7. F. Brauer, Models for diseases with vertical transmission and nonlinear population dynamics, Math. Biosci. 128 (1995), pp. 13-24.
8. S.N. Busenberg and K.L. Cooke, Models of Vertically Transmitted Diseases with Sequencialcontinuous Dynamics, in Nonlinear Phenomena In Mathematical Sciences, V. Lakshmikantam, ed., Academic Press, New York, 1982, pp. 179-187.
9. S.N. Busenberg, K.L. Cooke, and M. Pozio, Analysis of a model of a vertically transmitted disease, J. Math. Biol. 17 (1983), pp. 305-329.
10. L.L. Cavalli-sforza and M.W. Feldman, Cultural transmission and evolution: A quantitative approach, Monographs in Population Biology Princeton, Univ. Press 16 (1983).
11. C.W. Clark, Economically optimal policies for the utilization of biologically renewable resources, Math. Biosci. 12 (1971), pp. 245-260.
12. A. d'Onofrio, Globally stable vaccine-induced eradication of horizontally and vertically transmitted infectious diseases with periodic contact rates and disease-dependent demographic factors in the population, Appl. Math. Comput. 140 (2003), pp. 537-547.
13. W.J. Edmunds, G.F. Medley, and D.J. Nokes, The transmission dynamics and control of hepatitis B virus in the Gambia, Stat. Med. 15 (1996a), pp. 2215-2233.
14. W.J. Edmunds, G.F. Medley, and D.J. Nokes, Vaccination against hepatitis B virus in highly endemic area: Waning vaccine-induced immunity and the need for booster doses, Trans. R. Soc. Trop. Med. Hyg. 90 (1996b), pp. 436-440.
15. M. El Doma, Stability analysis of a general age-dependent vaccination model for a vertically transmitted disease under the proportionate mixing assumption, IMA J. Math. Appl. Med. Biol. 17 (2000), pp. 119-136.
16. G. Fattovich, F. Bortolotti, and F. Donato, Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors, J. Hepatol. 48 (2008), pp. 335-352.
17. S. Ghosh and D.K. Bhattacharyya, Optimization in microbial pest control: An Integrated approach, Appl. Math. Model. 34 (2010) 1382-1395.
18. B.S. Goh, J. Leitman, and T.L. Vincent, Optimal control of prey-predator systems, Math. BioSci. 19 (1974), pp. 263-286.
19. B. Hethcote, H. Stech, and P. van den Driessche, Periodicity and Stability in Epidemic Models, in Differential Equations and Applications to Ecology, Epidemics, and Population Problems, S.N. Busenberg and K.L. Cooke, eds., Academic press, New York, 1981, pp. 65-82.
20. E.O. Jonesa, A. Whiteb, and M. Boots, Interference and the persistence of vertically transmitted parasites, J. Theor. Biol. 246 (2007), pp. 10-17.
21. E.B. Keeffe, Acute hepatitis A and B in patients with chronic liver disease: Prevention through vaccination, Am. J. Med. 118 (2005), pp. 21S-27S.
22. K. Krogsgaard et al., Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B, J. Hepatol. 25 (1996), pp. 795-802.
23. M.Y. Li, H.L. Smith, and L. Wang, Global dynamics of an SEIR epidemic model with vertical transmission, SIAM J. Appl. Math. 62 (2001), pp. 58-69.
24. MMWR, Progress in hepatitisB prevention through universal infant vaccination in China 1997-2006, Morb. Mortal. Wkly. Rep. 56(18) (2007), pp. 441-445.
25. R. Naresh, A. Tripathi, and S. Omar, Modelling the spread of AIDS epidemic with vertical transmission, Appl. Math. Comput. 178 (2006), pp. 262-272.
26. B.J. Nassal, Hepatitis B virus replication, World J. Gastroenterol. 13(1) (2007), pp. 48-64.
27. R.P. Perrillo, Chronic hepatitis B: A critical appraisal of current to therapy, Clin. Gastroentrol. Hepatol. 4 (2006), pp. 233-248.
28. M.R. Razvan, The dynamics of a vertically transmitted disease, J. Prime Res. Math. 3 (2007), pp. 201-209.
29. J. Rosenau et al., Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection, J. Hepatol. 34 (2001a), pp. 895-902.
30. J. Rosenau et al., Successful hepatitis B reinfection prophylaxis with Lamivudine and hepatitis b immune globulin in patients with positive HBV-DNA at time of liver transplantation, Transplant. Proc. 33 (2001b), pp. 3637-3638.
31. H.R. Thieme, Mathematics in Population Biology, Princeton University Press, Princeton, NJ, 2003.
32. D.L. Veenstra et al., Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: A cost-effectiveness analysis, Aliment. Pharmacol. Ther. 27 (2008), pp. 1240-1252.
33. T.L. Wright and J.Y.N. Lau, Clinical aspects of hepatitis B virus infection, Lancet 342 (1993), pp. 1340-1344.
34. L. Zou, W. Zhang, and S. Ruan, Modelling the transmission dynamics and control of hepatitis B virus in China, J. Theor. Biol. 262 (2010), pp. 330-338.